Merck & Co. didn’t do any significant studies on whether Vioxx could cause heart attacks or other serious cardiovascular problems before the popular painkiller went on the market in 1999, the ...

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- Merck today announced a non-exclusive license agreement with Laboratory Corporation of America ® Holdings (LabCorp ®) for the commercialization of a genetic ...

Merck (NYSE:MRK) has initiated a late-stage trial to test its experimental drug, MK-1084, in combination with its anti-PD1 immunotherapy KEYTRUDA (pembrolizumab) for the first-line treatment of ...

Signage is seen at the Merck & Co. headquarters in Kenilworth, New Jersey (Reuters) - Merck & Co said on Wednesday it plans to conduct clinical trials testing its human papillomavirus (HPV) vaccine ...

Merck has tightened its ties to Starpharma as it continues to build out its antibody-drug conjugate (ADC) capabilities, signing a second agreement that will enable it to evaluate candidates based on a ...

If you can’t beat 'em, join 'em: Roche is teaming up with its immuno-oncology competitor Merck & Co. to develop a pan-cancer companion diagnostic test for its Keytruda therapy aimed at detecting the ...

Merck is partnering with a digital health startup to see if smartphone data can be used to identify digital endpoints for Alzheimer’s drug development. The study will use a research platform developed ...

There has been a lot of talk about how blockchain computer technology can better protect the U.S. drug supply chain. Merck & Co. intends to test that theory. The U.S. drugmaker has been invited by the ...

AT&T is taking part in a proof of concept with Softbox to test connected medical payloads carried by drones. The goal? Successfully and safely deliver temperature-sensitive medicines using drones. An ...

Merck & Co. is expanding its partnership with the mRNA company Moderna Therapeutics. Under the deal, Merck will make a $125 million investment into Moderna. In addition, the big drug company will ...

(Reuters) - Pivotal trial results for Merck & Co Inc's immunotherapy drug Keytruda show that it lengthened survival by three months, or nearly 40 percent, for patients with advanced bladder cancer who ...

Dow component Merck & Co., Inc. (MRK) ended more than four years of laggard behavior in the second half of 2018, turning sharply higher in a positive feedback loop that has now lifted shares of the ...